Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics
Open Access
- 5 August 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 17 (12), 1506-1516
- https://doi.org/10.1038/gt.2010.103
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Vesicular Stomatitis Virus Genomic RNA PersistsIn Vivoin the Absence of Viral ReplicationJournal of Virology, 2010
- Measles Virus Selectively Blind to Signaling Lymphocytic Activation Molecule (SLAM; CD150) Is Attenuated and Induces Strong Adaptive Immune Responses in Rhesus MonkeysJournal of Virology, 2010
- Intelligent Design: Combination Therapy With Oncolytic VirusesMolecular Therapy, 2010
- Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian CancerCancer Research, 2010
- A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1984Molecular Therapy, 2009
- Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of ReovirusClinical Cancer Research, 2008
- Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without CyclophosphamideClinical Pharmacology & Therapeutics, 2007
- Depletion of Peripheral Macrophages and Brain Microglia Increases Brain Tumor Titers of Oncolytic VirusesCancer Research, 2007
- Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesProceedings of the National Academy of Sciences of the United States of America, 2006
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1931